Avantis appoints new CEO, CFO
Avantis Medical Systems, a visualization technology company focused on the detection and prevention of cancers of the gastrointestinal tract, has appointed Scott Dodson as president and CEO and Larry Tannenbaum as senior vice president and chief financial officer (CFO).
Dodson is a medical device executive with a 20-year career. From 1992 to 2006, he was with Boston Scientific in its urology, endoscopy and international business units, and also served from 2004 through 2006 as vice president of global marketing in the company’s endoscopy business unit, the Sunnyvale, Calif.-based Avantis said. From 2006 to 2008, Dodson was president of the orthopedic business for Orthofix.
Tannenbaum’s career in finance spans more than 30 years, the company said. Most recently, he served in executive positions at Iridex as senior vice president and chief business officer, as well as CFO. Prior to Iridex, Tannenbaum also worked in senior management positions for LJL Biosystems, Metrika (now Bayer Diagnostics), drug manufacturer Sinogen and Target Therapeutics (now Boston Scientific), Avantis said.
Dodson is a medical device executive with a 20-year career. From 1992 to 2006, he was with Boston Scientific in its urology, endoscopy and international business units, and also served from 2004 through 2006 as vice president of global marketing in the company’s endoscopy business unit, the Sunnyvale, Calif.-based Avantis said. From 2006 to 2008, Dodson was president of the orthopedic business for Orthofix.
Tannenbaum’s career in finance spans more than 30 years, the company said. Most recently, he served in executive positions at Iridex as senior vice president and chief business officer, as well as CFO. Prior to Iridex, Tannenbaum also worked in senior management positions for LJL Biosystems, Metrika (now Bayer Diagnostics), drug manufacturer Sinogen and Target Therapeutics (now Boston Scientific), Avantis said.